Researchers at Peter Mac have made a key discovery in liver regeneration that may have important implications for liver cancer. Joint research by Associate Professor Andrew Cox and Professor Mark Dawson, published Feb. 15 ...
Feb 19, 2024
0
69
Therapeutic cancer vaccines are an appealing strategy for treating malignancies. In theory, when a patient is injected with peptide antigens—protein fragments from mutant proteins only expressed by tumor cells—T cells ...
Feb 16, 2024
0
8
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients ...
Feb 16, 2024
0
65
According to the Alzheimer's Association, more than 6.5 million Americans are living with Alzheimer's disease, and one in three older adults will die with the disease or another form of dementia. There's also a growing need ...
Feb 15, 2024
0
0
Biomarkers are measurable characteristics that can be used to evaluate normal biological processes, diseases, or responses to treatment in patients. Using biomarkers to assess biological aging, or the increase in molecular ...
Feb 14, 2024
0
38
Immunotherapy is already improving treatment options for many cancer types, but research groups keep exploring ways to boost the body's immune response against the tumor.
Feb 14, 2024
0
20
Putting a computer inside someone's brain used to feel like the edge of science fiction. Today, it's a reality. Academic and commercial groups are testing "brain-computer interface" devices to enable people with disabilities ...
Feb 14, 2024
0
1
It was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and antibiotics were no longer working.
Feb 14, 2024
0
13
For the first time, Purdue researchers prove that measuring mechanical motions in living cancer tissues is a viable and promising approach for predicting chemoresistance
Feb 14, 2024
0
22
The quality of evidence submitted to the National Institute for Health and Care Excellence (NICE) for informing its decisions to recommend technologies for use in the NHS was poor in more than half of cases, reveals a 20-year ...
Feb 13, 2024
0
0
